CAS: 2099128-41-1
Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
5-Fluoro-4-(7'-fluoro-2'-methylspiro[cyclopentane-1,3'-[3H]indol]-5'-yl)-N-[5-(1-methyl-4-piperidinyl)-2-pyridinyl]-2-pyrimidinamine REF: TR-F209910CAS: 2099128-41-1 | - - - | 17.889,00 € | Lun 13 Gen 25 | |
CDK4/6/1 Inhibitor REF: TM-T10735CAS: 2099128-41-1 | 97.99% - 99.26% | 306,00 €~2.721,00 € | Mar 21 Gen 25 |
5-Fluoro-4-(7'-fluoro-2'-methylspiro[cyclopentane-1,3'-[3H]indol]-5'-yl)-N-[5-(1-methyl-4-piperidinyl)-2-pyridinyl]-2-pyrimidinamine
Prodotto ControllatoCAS:2099128-41-1
Formula:
C28H30F2N6
Colore e forma:
Neat
Peso molecolare:
488.575
Ref: TR-F209910
25mg | 17.889,00 € |
Consegna stimata in Stati Uniti, il Lunedì 13 Gennaio 2025
CDK4/6/1 Inhibitor
CAS:2099128-41-1
CDK4/6/1 Inhibitor (Crozbaciclib) is a type of CDK4/6 inhibitor (IC50s: 3 and 1 nM).
Formula:
C28H30F2N6
Purezza:
97.99% - 99.26%
Colore e forma:
Solid
Peso molecolare:
488.57
Ref: TM-T10735
1mg | 306,00 € | ||
5mg | 742,00 € | ||
10mg | 1.016,00 € | ||
25mg | 1.532,00 € | ||
50mg | 2.070,00 € | ||
100mg | 2.721,00 € |
Consegna stimata in Stati Uniti, il Martedì 21 Gennaio 2025